Literature DB >> 17289925

Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension.

Cécile Cayla1, Mihail Todiras, Radu Iliescu, Vera V Saul, Volkmar Gross, Bernhard Pilz, Guixuan Chai, Vanessa F Merino, João B Pesquero, Ovidiu C Baltatu, Michael Bader.   

Abstract

Kinins play a central role in the modulation of cardiovascular function and in the pathophysiology of inflammation. These peptides mediate their effects by binding to two specific G-protein coupled receptors named B1 and B2. To evaluate the full functional relevance of the kallikrein-kinin system, we generated mice lacking both kinin receptors (B1B2-/-). Because of the close chromosomal position of both kinin receptor genes, B1B2-/- mice could not be obtained by simple breeding of the single knockout lines. Therefore, we inactivated the B1 receptor gene by homologous recombination in embryonic stem cells derived from B2-deficient animals. The B1B2-/- mice exhibited undetectable levels of mRNAs for both receptors and a lack of response to bradykinin (B2 agonist) and des-Arg9-bradykinin (B1 agonist), as attested by contractility studies with isolated smooth muscle tissues. B1B2-/- mice are healthy and fertile, and no sign of cardiac abnormality was detected. They are normotensive but exhibit a lower heart rate than controls. Furthermore, kinin receptor deficiency affects the pathogenesis of endotoxin-induced hypotension. While blood pressure decreased markedly in wild-type mice and B2-/- and moderately in B1-/- mice after bacterial lipopolysaccharide (LPS) injection, blood pressure remained unchanged in B1B2-/- mice. These results clearly demonstrate a pivotal role of kinins and their receptors in hypotension induced by endotoxemia in mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289925     DOI: 10.1096/fj.06-7175com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  30 in total

1.  Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice.

Authors:  Adam R Wende; Jamie Soto; Curtis D Olsen; Karla M P Pires; John C Schell; Frederic Larrieu-Lahargue; Sheldon E Litwin; Masao Kakoki; Nobuyuki Takahashi; Oliver Smithies; E Dale Abel
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

2.  Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012.

Authors:  Markus Magerl; Michael Bader; Anne Gompel; Kusumam Joseph; Allen P Kaplan; Georg Kojda; Thomas Renné; Markus Wirth; Marcus Maurer; Martin K Church
Journal:  Inflamm Res       Date:  2013-12-08       Impact factor: 4.575

3.  Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.

Authors:  Masao Kakoki; Kelli A Sullivan; Carey Backus; John M Hayes; Sang Su Oh; Kunjie Hua; Adil M H Gasim; Hirofumi Tomita; Ruriko Grant; Sarah B Nossov; Hyung-Suk Kim; J Charles Jennette; Eva L Feldman; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

4.  Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B(1) receptors.

Authors:  Vanessa F Merino; Mihail Todiras; Luciana A Campos; Vera Saul; Elena Popova; Ovidiu C Baltatu; João B Pesquero; Michael Bader
Journal:  J Mol Med (Berl)       Date:  2008-04-19       Impact factor: 4.599

5.  Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system.

Authors:  Ulf Schulze-Topphoff; Alexandre Prat; Timour Prozorovski; Volker Siffrin; Magdalena Paterka; Josephine Herz; Ivo Bendix; Igal Ifergan; Ines Schadock; Marcelo A Mori; Jack Van Horssen; Friederike Schröter; Alina Smorodchenko; May Htwe Han; Michael Bader; Lawrence Steinman; Orhan Aktas; Frauke Zipp
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

6.  Bradykinin increases BP in endotoxemic rat: functional and biochemical evidence of angiotensin II AT1 /bradykinin B2 receptor heterodimerization.

Authors:  Elaine Leocádia Anton; Daniel Fernandes; Jamil Assreuy; José Eduardo da Silva-Santos
Journal:  Br J Pharmacol       Date:  2019-05-13       Impact factor: 8.739

Review 7.  Contact system activation in severe infectious diseases.

Authors:  Sonja Oehmcke; Heiko Herwald
Journal:  J Mol Med (Berl)       Date:  2010-02       Impact factor: 4.599

8.  Early Increased Bradykinin 1 Receptor Contributes to Hemorrhagic Transformation After Ischemic Stroke in Type 1 Diabetic Rats.

Authors:  Hongfei Sang; Zhongming Qiu; Jin Cai; Wenya Lan; Linjie Yu; Hao Zhang; Min Li; Yi Xie; Ruibing Guo; Ruidong Ye; Xinfeng Liu; Ling Liu; Renliang Zhang
Journal:  Transl Stroke Res       Date:  2017-07-19       Impact factor: 6.829

9.  Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models.

Authors:  Brunella Cristofaro; Yu Shi; Marcella Faria; Steven Suchting; Aurelie S Leroyer; Alexandre Trindade; Antonio Duarte; Ann C Zovein; M Luisa Iruela-Arispe; Lina R Nih; Nathalie Kubis; Daniel Henrion; Laurent Loufrani; Mihail Todiras; Johanna Schleifenbaum; Maik Gollasch; Zhen W Zhuang; Michael Simons; Anne Eichmann; Ferdinand le Noble
Journal:  Development       Date:  2013-04       Impact factor: 6.868

10.  Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.

Authors:  Dirk Westermann; Thomas Walther; Konstantinos Savvatis; Felcicitas Escher; Meike Sobirey; Alexander Riad; Michael Bader; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.